F33D4.4 Antibody

What is Frizzled-4 and why is it significant in research?

Frizzled-4 (FZD4) is a member of the Frizzled family, functioning as a receptor for Wnt proteins and norrin. It is a 48-53 kDa seven-transmembrane G-protein-coupled receptor involved in the activation of Wnt/β-catenin pathway. FZD4 is expressed in multiple tissues including kidney, lung, brain, and liver, and serves as a neuronal stem cell marker. Its significance in research stems from its critical roles in retinal and inner ear angiogenesis, embryonic development, tissue and cell polarization, and proliferation. Understanding FZD4 provides insights into developmental biology, stem cell research, and pathological conditions related to abnormal Wnt signaling .

What are the primary applications of Frizzled-4 antibodies in research?

Frizzled-4 antibodies are employed in multiple research applications:

• Western Blot (WB): For protein expression analysis and quantification

• Immunohistochemistry (IHC): For tissue localization studies

• Flow Cytometry (FC): For cell sorting and identification of FZD4-expressing cells

• Immunocytochemistry (ICC): For cellular localization studies

These applications enable researchers to investigate FZD4 expression patterns, identify FZD4-positive cell populations, and study the role of FZD4 in various biological processes and disease states .

How can I validate the specificity of a Frizzled-4 antibody?

To validate specificity of a Frizzled-4 antibody:

• Compare staining patterns between wild-type and FZD4-knockout models

• Perform peptide competition assays using the immunogenic peptide

• Test multiple antibodies targeting different epitopes of FZD4

• Verify molecular weight specificity via Western blot (expected MW: ~60-65 kDa)

• Include positive controls (tissues known to express FZD4 such as kidney and brain)

• Include negative controls (secondary antibody only)

• Verify cross-reactivity profiles across species of interest before experimentation

This comprehensive validation approach ensures reliable results in downstream applications .

How can Frizzled-4 antibodies be utilized for isolation of neural progenitor cells?

Frizzled-4 antibodies have proven valuable for isolating enteric neural progenitor cells through fluorescence-activated cell sorting (FACS). The methodology involves:

• Preparing cell suspensions from tissue samples (e.g., human tunica muscularis)

• Staining with PE-conjugated anti-frizzled-4 antibodies

• FACS sorting using appropriate parameters (e.g., 488 nm laser excitation, 576/26 nm emission filter)

• Culturing sorted cells in appropriate media supplemented with growth factors (B27, EGF, FGF, Y-27632, Wnt3a)

Frizzled-4 positive cells obtained through this method form neurosphere-like bodies and differentiate into neurons and glial cells, demonstrating their progenitor nature. This approach offers advantages over traditional p75NTR-based isolation by providing a more precise marker for neurogenic cells .

What is the relationship between Frizzled-4 and the canonical Wnt signaling pathway in experimental contexts?

In experimental settings, Frizzled-4 functions as a critical receptor in the canonical Wnt/β-catenin signaling pathway:

• FZD4 acts as a receptor for both Wnt proteins and non-Wnt ligands like Norrin

• Upon ligand binding, FZD4 activation leads to disheveled proteins activation

• This inhibits GSK-3 kinase, preventing β-catenin phosphorylation and degradation

• Nuclear accumulation of β-catenin activates LEF/TCF-mediated transcriptional programs

Experimental manipulation of FZD4 through mutations, particularly in the TM5-ICL3-TM6 and ICL2 regions, substantially decreases both basal activity and ligand-induced activity (Norrin and WNT3a). This confirms these regions' crucial roles in downstream signaling, particularly through engagement with Dishevelled (DVL) proteins .

How can researchers determine if Frizzled-4 antibodies affect receptor function in live cell assays?

To determine if Frizzled-4 antibodies affect receptor function:

• Compare Wnt signaling responses (using TOPFlash or similar reporter assays) in the presence and absence of antibodies

• Measure calcium flux using calcium-sensitive dyes or genetically encoded calcium indicators

• Assess receptor internalization rates using fluorescently-tagged FZD4

• Monitor phosphorylation status of downstream effectors (e.g., LRP6, DVL2)

• Perform FRET-based interaction studies between FZD4 and its binding partners

• Test competitive binding with natural ligands (Wnt proteins, Norrin)

These functional approaches provide insights into whether antibodies act as agonists, antagonists, or have no effect on receptor function .

What are optimal sample preparation methods for detecting Frizzled-4 in different applications?

Sample preparation varies by application type:

For Western Blot:

• Lyse tissues/cells in RIPA buffer supplemented with protease inhibitors

• Include phosphatase inhibitors if phosphorylation status is important

• Heat samples to 70°C (not 95°C) to prevent aggregation of transmembrane proteins

• Use 8-10% acrylamide gels for optimal resolution

For Immunohistochemistry:

• For paraffin sections: Use antigen retrieval (citrate buffer pH 6.0 or EDTA buffer pH 9.0)

• For frozen sections: Fix with 4% paraformaldehyde (10 minutes)

• Block with 5-10% normal serum from secondary antibody species

For Flow Cytometry:

• Use gentle dissociation methods (avoid trypsin if possible)

• Block Fc receptors to prevent non-specific binding

• Optimize antibody concentration carefully (typically 5μl per million cells)

How can researchers address epitope masking issues when using Frizzled-4 antibodies?

To address epitope masking issues:

• Denaturation strategies:

  • Test different fixation methods (PFA, methanol, acetone)

  • Compare multiple antigen retrieval approaches (heat-induced vs. enzymatic)

  • Adjust pH conditions during retrieval (acidic vs. basic buffers)

• Antibody selection approaches:

  • Use antibodies targeting different epitopes (N-terminus vs. C-terminus)

  • Test antibodies raised against different immunogens (peptide vs. full protein)

  • Consider conformation-specific vs. denaturation-dependent antibodies

• Sample preparation modifications:

  • Reduce cross-linking time in fixation protocols

  • Use detergents to increase membrane permeability

  • Consider native vs. denaturing conditions based on epitope accessibility

What techniques can be used to quantify Frizzled-4 expression levels with high precision?

For precise quantification of Frizzled-4 expression:

For most accurate results, researchers should combine complementary approaches such as qRT-PCR with Western blot or flow cytometry with immunofluorescence to verify expression at both transcript and protein levels .

How can researchers overcome cross-reactivity issues with Frizzled-4 antibodies?

To overcome cross-reactivity issues:

• Validation strategies:

  • Perform absorption tests with recombinant Frizzled family proteins

  • Test antibody specificity in FZD4 knockout or knockdown systems

  • Compare staining patterns with multiple antibodies against different epitopes

• Optimization approaches:

  • Titrate antibody concentration to minimize non-specific binding

  • Increase blocking duration and concentration (5-10% normal serum)

  • Include competitive blocking agents for common cross-reactive epitopes

  • Adjust incubation temperature (4°C overnight vs. room temperature)

• Alternative detection methods:

  • Consider direct labeling of primary antibodies to eliminate secondary antibody cross-reactivity

  • Use highly cross-adsorbed secondary antibodies

  • Employ tyramide signal amplification for improved signal-to-noise ratio

What experimental controls are essential when investigating Frizzled-4 signaling pathways?

Essential controls for Frizzled-4 signaling studies include:

• Positive controls:

  • Tissues/cells known to express high FZD4 levels (kidney, brain)

  • Wnt3a or Norrin stimulation to activate canonical pathway

  • Constitutively active β-catenin constructs

• Negative controls:

  • FZD4 knockout/knockdown cells

  • Competitive inhibition with soluble FZD4-CRD domain

  • DVL1/2/3 triple knockout cells to eliminate downstream signaling

• Pathway-specific controls:

  • GSK3β inhibitors (e.g., CHIR99021) to mimic pathway activation

  • Tankyrase inhibitors (e.g., XAV939) to inhibit pathway

  • β-catenin nuclear translocation assessment

• Antibody controls:

  • Isotype controls matched to primary antibody

  • Secondary antibody-only controls

  • Peptide competition assays

How can researchers integrate Frizzled-4 antibody studies with functional genomics approaches?

Integration strategies include:

• CRISPR-Cas9 applications:

  • Generate FZD4 knockout lines to validate antibody specificity

  • Create knock-in reporter lines (GFP-tagged FZD4) for live tracking

  • Perform domain-specific mutations to correlate structure with antibody binding

• Transcriptomic integration:

  • Correlate protein expression (antibody-based) with RNA-seq data

  • Perform ChIP-seq using anti-FZD4 antibodies to identify binding partners

  • Use single-cell approaches to connect FZD4 expression with cell states

• Proteomic approaches:

  • Conduct immunoprecipitation with anti-FZD4 antibodies followed by mass spectrometry

  • Perform proximity labeling (BioID, APEX) with FZD4 as bait

  • Integrate phosphoproteomics to map signaling networks

These integrated approaches provide comprehensive understanding of FZD4 biology beyond expression patterns .

How can Frizzled-4 antibodies contribute to understanding stem cell differentiation pathways?

Frizzled-4 antibodies enable key insights into stem cell biology through:

• Lineage tracking:

  • FACS isolation of FZD4+ progenitor populations from mixed cultures

  • Time-course analysis of FZD4 expression during differentiation

  • Correlation of FZD4 levels with developmental stage markers

• Mechanistic investigations:

  • Blocking antibodies to inhibit specific FZD4-ligand interactions

  • Chromatin immunoprecipitation to identify FZD4-regulated genes

  • Live imaging of FZD4 dynamics during differentiation decisions

• Therapeutic applications:

  • Purification of specific neural progenitor populations for transplantation

  • Directing differentiation through modulation of FZD4 signaling

  • Development of FZD4-targeted delivery systems for stem cell niches

These approaches help delineate the temporal and functional roles of FZD4 in stem cell maintenance and differentiation, particularly in neural development contexts .

What are the emerging applications of recombinant antibody technologies for studying Frizzled-4?

Emerging recombinant antibody technologies enable:

• Single-chain variable fragments (scFvs):

  • Development of intrabodies for tracking FZD4 in live cells

  • Creation of conformation-specific antibodies distinguishing active/inactive states

  • Generation of bispecific antibodies targeting FZD4 and co-receptors simultaneously

• Antibody engineering approaches:

  • Nanobody development for improved tissue penetration

  • Site-specific conjugation for precise imaging or delivery applications

  • Humanized antibodies for potential therapeutic development

• Rapid generation methods:

  • Using minigene expression cassettes for quick antibody production

  • Applying transcriptionally active PCR techniques

  • Leveraging phage display libraries for epitope-specific selection

These technologies expand the toolkit for FZD4 research beyond conventional antibody applications .

How might Frizzled-4 antibodies inform therapeutic approaches for diseases involving Wnt signaling dysregulation?

Frizzled-4 antibodies provide insights for therapeutic development:

• Diagnostic applications:

  • Identification of patient populations with altered FZD4 expression

  • Monitoring treatment responses through FZD4 pathway biomarkers

  • Development of companion diagnostics for Wnt-targeted therapies

• Therapeutic design strategies:

  • Structure-guided development of antibodies targeting specific FZD4 domains

  • Creation of antibody-drug conjugates for targeted delivery to FZD4+ cells

  • Engineering Fc-modified antibodies with optimized effector functions

• Combination approaches:

  • Targeting multiple Wnt pathway components simultaneously

  • Integrating FZD4-based therapies with standard treatment regimens

  • Developing bispecific molecules that redirect endogenous antibodies to FZD4

These applications leverage structural understanding of FZD4-ligand interactions and receptor conformational dynamics to create more specific and effective therapeutic approaches .